Angela Morgan
Papers
2
Total Citations
346
H-Index
2
About
Angela Morgan is a leading urologic oncologist whose research is redefining surgical standards for bladder cancer. Her primary focus is on comparing robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC) against traditional open radical cystectomy (ORC). Her landmark 2022 study, cited over 320 times, provided pivotal evidence that iRARC significantly reduces 90-day morbidity and hospital stays without compromising oncologic outcomes, challenging long-held surgical norms. Building on this, her 2023 cost-effectiveness analysis (26 citations) demonstrated that while iRARC has higher upfront costs, it offers superior value by reducing complications and readmissions, making a compelling economic case for adoption. Morgan’s work directly informs clinical guidelines and hospital policy, bridging the gap between surgical innovation and real-world patient recovery. By rigorously evaluating both clinical efficacy and healthcare economics, she has established herself as a key voice in evidence-based surgical oncology, helping to shape the future of minimally invasive bladder cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2